Bradner, James E.
Amgen Incorporated,
United States
2025 Rank: 36105
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1252 out of 157999 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36105 | 39434 |
| Total Cites | 47300 | 52125 |
| H-index | 109 | 115 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 25 | 25 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1679 | 1806 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 9856 | 10713 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 30450 | 32628 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.60 |
| Self-Citation Percentage |
9.26%
|
|
Bradner, James E.
Harvard Medical School,
United States
2024 Rank: 37139
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1311 out of 149337 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37139 | 40368 |
| Total Cites | 43078 | 47636 |
| H-index | 102 | 110 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 24 | 24 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1530 | 1655 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 8873 | 9699 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 27527 | 29572 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.61 |
| Self-Citation Percentage |
9.57%
|
|
Bradner, James E.
Novartis Institutes for BioMedical Research, Inc.,
United States
2023 Rank: 38407
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1372 out of 138178 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38407 | 40831 |
| Total Cites | 38567 | 42921 |
| H-index | 97 | 107 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 24 | 24 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1363 | 1482 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 7856 | 8653 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 24575 | 26479 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.62 |
| Self-Citation Percentage |
10.14%
|
|
Bradner, James E.
Harvard Medical School,
United States
2022 Rank: 39422
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 1766 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39422 | 42201 |
| Total Cites | 33500 | 37486 |
| H-index | 92 | 101 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 24 | 24 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 1150 | 1266 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 6758 | 7505 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 21356 | 23082 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.62 |
| Self-Citation Percentage |
10.63%
|
|
Bradner, James E.
Harvard Medical School,
United States
2021 Rank: 39928
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 1776 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39928 | 42976 |
| Total Cites | 31013 | 34842 |
| H-index | 88 | 96 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 24 | 24 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 1058 | 1171 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 6257 | 6977 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 19815 | 21464 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.62 |
| Self-Citation Percentage |
10.99%
|
|
Bradner, James E.
Harvard Medical School,
United States
2020 Rank: 48011
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 2190 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48011 | 50108 |
| Total Cites | 24685 | 27921 |
| H-index | 76 | 85 |
| Hm-index | 17 | 17 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 21 | 21 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 835 | 933 |
| Number of Single+First+Last Authored Papers | 42 | 42 |
| Total Cites to Single+First+Last Authored Papers | 4906 | 5506 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15916 | 17347 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.61 |
| Self-Citation Percentage |
11.59%
|
|